BGB Rejects Natraceutical Call

Mar 9, 2011

Bio Group Brazil (BGB) says it has rejected a call option on a 46.8% stake in Natraceutical, valued at EUR66m. BGB received...

To continue reading please take a free trial, subscribe or login below.


Already have an account?

Subscribe

Subscribe now for unlimited access to all current and archive news, data and market analysis. 

Subscribe

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

Upcoming Events

Poll

Which area will be most profitable for investment banks in LatAm in 2016?

Vote    




Popular Searches